BIANCA BAE: Open Payments
NPI 1992339477 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 11 payments from 6 companies in 2025. Trend: 2023 $619 · 2024 $459 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 2 | $128 |
| Astellas Pharma US Inc | 2 | $70 |
| ABBVIE INC. | 3 | $64 |
| Sage Therapeutics, LLC | 2 | $47 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $16 |
Products named: ANNOVERA, Veozah, ZURZUVAE, LILETTA, LO LOESTRIN FE, Qelbree, Phexxi.
Industry payments across CA — which companies pay providers there.
